Could Human Papillomaviruses Be Spread through Blood?
-
Published:2005-11
Issue:11
Volume:43
Page:5428-5434
-
ISSN:0095-1137
-
Container-title:Journal of Clinical Microbiology
-
language:en
-
Short-container-title:J Clin Microbiol
Author:
Bodaghi Sohrab1, Wood Lauren V.1, Roby Gregg1, Ryder Celia1, Steinberg Seth M.2, Zheng Zhi-Ming1
Affiliation:
1. HIV and AIDS Malignancy Branch 2. Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Abstract
ABSTRACT
The
human papillomaviruses (HPVs) are epitheliotropic viruses that require
the environment of a differentiating squamous epithelium for their life
cycle. HPV infection through abrasion of the skin or sexual intercourse
causes benign warts and sometimes cancer. HPV DNA detected in the blood
has been interpreted as having originated from metastasized cancer
cells. The present study examined HPV DNA in banked, frozen peripheral
blood mononuclear cells (PBMCs) from 57 U.S. human immunodeficiency
virus (HIV)-infected pediatric patients collected between 1987 and 1996
and in fresh PBMCs from 19 healthy blood donors collected in 2002 to
2003. Eight patients and three blood donors were positive mostly for
two subgroups of the HPV type 16 genome. The HPV genome detected in all
11 PBMC samples existed as an episomal form, albeit at a low DNA copy
number. Among the eight patients, seven acquired HIV from transfusion
(three associated with hemophilia) and one acquired HIV through
vertical transmission; this patient also had received a transfusion
before sampling. Our data suggest that PBMCs may be HPV carriers and
might spread the virus through
blood.
Publisher
American Society for Microbiology
Subject
Microbiology (medical)
Reference47 articles.
1. Ahdieh, L., R. S. Klein, R. Burk, S. Cu-Uvin, P. Schuman, A. Duerr, M. Safaeian, J. Astemborski, R. Daniel, and K. Shah. 2001 . Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis.184:682-690. 2. Bernard, H. U., S. Y. Chan, M. M. Manos, C. K. Ong, L. L. Villa, H. Delius, C. L. Peyton, H. M. Bauer, and C. M. Wheeler. 1994 . Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis.170:1077-1085. 3. Bodaghi, S., K. Yamanegi, S. Y. Xiao, M. Da Costa, J. M. Palefsky, and Z. M. Zheng. 2005. Colorectal papillomavirus infection in patients with colorectal cancer.Clin. Cancer Res.11:2862-2867. 4. Burk, R. D., M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, R. Mortel, P. E. Schwartz, and A. Hildesheim. 2003 . Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.Cancer Res.63:7215-7220. 5. Capone, R. B., S. I. Pai, W. M. Koch, M. L. Gillison, H. N. Danish, W. H. Westra, R. Daniel, K. V. Shah, and D. Sidransky. 2000 . Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin. Cancer Res.6:4171-4175.
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|